These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 26936428)

  • 1. The importance of surgical margins in renal cell and urothelial carcinomas.
    Alemozaffar M; Filson CP; Master VA
    J Surg Oncol; 2016 Mar; 113(3):316-22. PubMed ID: 26936428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of intraoperative frozen sections during radical cystectomy does not affect disease-free or overall survival: a study of 364 patients with urothelial carcinoma of the urinary bladder.
    Reder NP; Maxwell SP; Pambuccian SE; Barkan GA
    Ann Diagn Pathol; 2015 Jun; 19(3):107-12. PubMed ID: 25800468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM; Cai J; Miranda G; Skinner DG; Stein JP
    J Urol; 2007 Jun; 177(6):2088-94. PubMed ID: 17509294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
    J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robotic nephrectomy for central renal tumors with intraoperative evaluation of tumor histology.
    Lieberman L; Barod R; Tapper A; Kumar R; Rogers C
    J Robot Surg; 2016 Sep; 10(3):261-5. PubMed ID: 27146858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy.
    Baumann BC; Guzzo TJ; He J; Vaughn DJ; Keefe SM; Vapiwala N; Deville C; Bekelman JE; Tucker K; Hwang WT; Malkowicz SB; Christodouleas JP
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):363-9. PubMed ID: 22658217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
    Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
    Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic management of upper-tract urothelial carcinoma.
    Raman JD; Park R
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):545-554. PubMed ID: 28480774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
    Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A;
    Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological outcomes of nephron sparing nephrectomy. 17-year analysis.
    Aguilera Bazan A; Bañuelos B; Alonso-Dorrego JM; Diez J; Cisneros J; De la Peña Barthel J
    Arch Esp Urol; 2014 Apr; 67(3):237-42. PubMed ID: 24840588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Margins for cervical and vulvar cancer.
    Khanna N; Rauh LA; Lachiewicz MP; Horowitz IR
    J Surg Oncol; 2016 Mar; 113(3):304-9. PubMed ID: 26852901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimally Invasive Therapy for Upper Tract Urothelial Cell Cancer.
    Pan S; Smith AD; Motamedinia P
    J Endourol; 2017 Mar; 31(3):238-245. PubMed ID: 28117602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an indication for frozen section examination of the ureteral margins during cystectomy for transitional cell carcinoma of the bladder?
    Schumacher MC; Scholz M; Weise ES; Fleischmann A; Thalmann GN; Studer UE
    J Urol; 2006 Dec; 176(6 Pt 1):2409-13; discussion 2413. PubMed ID: 17085117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upper urinary tract tumour after radical cystectomy for transitional cell carcinoma of the bladder: an update on the risk factors, surveillance regimens and treatments.
    Sanderson KM; Rouprêt M
    BJU Int; 2007 Jul; 100(1):11-6. PubMed ID: 17428248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.